Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

A Retrospective Follow Up Study to Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00110656

Enrollment

Registered

2005-05-13

Start date

2004-03-31

Completion date

2004-10-31

Last updated

2011-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplantation

Keywords

Kidney transplant

Brief summary

The purpose of this study is to collect local laboratory data on immunoreactive parathyroid hormone (iPTH), calcium and phosphorus levels and estimated glomerular filtration rate (GFR) at approximately 1 week, 1 month, 3 months, 6 months and 12 months after the kidney transplant.

Interventions

OTHERObservations

This is a non-interventional study- only observational.

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Patients who withdrew from one of the qualifying studies (i.e. patient previously took part in an Amgen study investigating the drug AMG 073 and its effects on secondary hyperparathyroidism \[HPT\]; in particular parathyroid hormone \[PTH\], calcium and phosphorus levels in blood associated with kidney failure) due to kidney transplantation.

Exclusion criteria

\- Patient has any kind of disorder that compromises the ability of the subject to give written informed consent

Design outcomes

Primary

Measure	Time frame
PTH Values	12 months post kidney translplant

Secondary

Measure	Time frame
Calcium and Phosphorus	12 months post kidney transplant

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026